Matthew P. Connor

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia”.

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025017526

N/A

0.267DataRank · unranked

3 citations

Chenyu Lin, David Nemirovsky, Sean Devlin, Kai Rejeski, Kevin J. Curran +43 more

Advancements in targeted therapies for acute myeloid leukemia

Current Opinion in Pharmacology(2025)10.1016/j.coph.2025.102604

N/A

0.104DataRank · unranked

1 citations

Adam Barsouk, Omar Elghawy, Catherine Lai, Matthew P. Connor

Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia

Haematologica(2024)10.3324/haematol.2024.285275

N/A

0DataRank · unranked

2 citations

Neeharika Prathapa, Noelle V. Frey, Saar Gill, Elizabeth O. Hexner, Ximena Bruno +13 more